Sixfold Bioscience completes $10.5M USD seed financing
Funding will support the advancement of Sixfold’s Mergo RNA therapeutics delivery platform, enabling delivery of mRNA and siRNA to tissues beyond the liver
07-Dec-2021 -
Sixfold Bioscience, a company harnessing computation and advanced chemistry to design RNA therapeutic delivery systems, announced it has raised a total of $10.5 million USD (£7.8 million GBP) in its seed funding round. The funding will support the continued development of the Company’s Mergo® RNA ...
funding
RNA
RNA therapeutics
+1